Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial

NCT06650579 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT06650579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06650579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial
Lead sponsor
Emory University
Phase
Phase 3
Overall status
Recruiting
Start date
January 31, 2025
Completion date
July 1, 2029
Enrollment
72 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent prostate carcinoma, stage iii prostate cancer ajcc v8, stage iva prostate cancer ajcc v8